Shamburg News · 8-K filed Oct 22, 2026, 4:30 PM EDT
Cardiff Oncology Stockholders Approve Increase in Authorized Capital Stock
CRDF · Cardiff Oncology, Inc.
- Shareholder vote
- Materiality: low
On October 22, 2026, Cardiff Oncology, Inc. held a special meeting of stockholders with 48,084,246 common shares represented, constituting a quorum. Stockholders approved an amendment to the certificate of incorporation increasing total authorized capital stock from 170,000,000 to 320,000,000 shares and common stock from 150,000,000 to 300,000,000 shares, with 37,675,355 votes for, 10,125,739 against and 283,147 abstaining.
Source: SEC EDGAR, Form 8-K, Item 5.07, accession 0001493152-26-048111.
Written from the filing by Shamburg Markets. Figures are as reported by the company.